| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 161 | 新穎化合物、潛在性添加劑及含該添加劑之組合物 | TW105128858 | 2016-09-07 | TW201713670A | 2017-04-16 | 松井依純; MATSUI, IZUMI; 鈴木智美; SUZUKI, TOMOMI; 岡田光裕; OKADA, MITSUHIRO |
| 本發明係一種下述通式(1)所表示之化合物。下述通式(1)中，R1 、R2 、R3 及R4 較佳為-CO-O-R11 ，尤佳為R11 係第三丁基之-CO-O-R11 。下述通式(1)中，R1 、R2 、R3 及R4 較佳為以-CO-O-R11 所表示之基。下述通式(1)所表示之化合物可適宜地用作潛在性添加劑。上述潛在性添加劑適宜用於感光性組合物。 | ||||||
| 162 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EP20800954.8 | 2020-11-10 | EP4058462A1 | 2022-09-21 | STENGEL, Ilona; LACKNER, Aaron; RODRIGUEZ, Lara-Isabel; WALTER, Charlotte; MEKIC, Amel |
| The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds. | ||||||
| 163 | NOVEL BENZIMIDAMIDES COMPOUNDS COMPRISING AN OXABORININ RING | EP19729249.3 | 2019-06-05 | EP3802550A1 | 2021-04-14 | LIDDLE, John; WALKER, Ann Louise; WHITE, Gemma Victoria |
| 164 | NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS | EP09829884.7 | 2009-12-02 | EP2370447B1 | 2016-07-27 | DONNELLY, Paul, Stephen; MA, Michelle, Therese; SCANLON, Denis, Bernard |
| The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention. | ||||||
| 165 | PLATELET ADP RECEPTOR INHIBITORS | EP10183633.6 | 2002-07-25 | EP2314593B1 | 2016-05-04 | Scarborough, Robert; Jantzen, Hans-Michael; Huang, Wolin; Sedlock, David; Marlowe, Charles; Kane-Maguire, Kim |
| 166 | NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS | EP09829884 | 2009-12-02 | EP2370447A4 | 2013-08-14 | DONNELLY PAUL STEPHEN; MA MICHELLE THERESE; SCANLON DENIS BERNARD |
| The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention. | ||||||
| 167 | Structural variants of mycolactones for use in modulating inflammation, immunity and pain | EP11306521.3 | 2011-11-18 | EP2594561A1 | 2013-05-22 | Demangel, Caroline; Blanchard, Nicolas; Bismuth, Georges; Eustache, Jacques; Casarotto, Virginie; Chany, Anne-Caroline |
The present invention is related to variants of mycolactones of formula (I), processes for the preparation thereof, pharmaceutical compositions thereof and their use in modulating inflammation, immunity and pain. |
||||||
| 168 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | EP04774798.5 | 2004-10-18 | EP1680479B1 | 2012-11-28 | KIM, Kong-Kyeom; LEE, Min-Jeong; KIM, Yeon-Hwan, 1612-801, Munchonmaul 16 Danji Apt; JANG, Jun-Gi, 7-401 LG Chemical Apartment |
| 169 | Dérivés de paraphénylènediamine à groupement pyrrolidinyle substitués par un radical cationique et utilisation de ces dérivés pour la coloration de fibres kératiniques | EP03290597.8 | 2003-03-11 | EP1348695B1 | 2012-04-25 | Sabelle, Stéphane; Ramos, Laure; Leduc, Madeleine, Rés. Les Chèvrefeuilles; Philippe, Michel |
| 170 | INHIBITORS OF HISTONE DEACETYLASE | EP08748100 | 2008-04-09 | EP2139850A4 | 2011-07-20 | TESSIER PIERRE; LEIT SILVANA; SMIL DAVID; DEZIEL ROBERT; AJAMIAN ALAIN; CHANTIGNY YVES ANDRE; DOMINGUEZ CELIA |
| This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of the Formula (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein groups L, M, X and Y are as defined herein. | ||||||
| 171 | DERIVES D'UREE CYCLIQUE, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE COMME INHIBITEURS DE KINASES | EP04705838.3 | 2004-01-28 | EP1599464B1 | 2010-09-22 | PATEK, Marcel; NAIR, Anil; HITTINGER, Augustin; NEMECEK, Conception; BOND, Daniel; HARLOW, Greg; BOUCHARD, Hervé; MAUGER, Jacques; MALLERON, Jean-Luc; PALERMO, Mark; AL-OBEIDI, Fahad; FAITG, Thomas; STROBEL, Hartmut; RUF, Sven; RITTER, Kurt; EL-AHMAD, Youssef; LESUISSE, Dominique; BENARD, Didier |
| The invention relates to novel products having formula (I), wherein: p denotes 0 to 2; R and R1 denote O or NH; R2 and R3 denote hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl, or R2 and R3, together with the carbon atom to which they are bound, form a carbocyclic or heterocyclic radical, all of said radicals being optionally substituted; A1 denotes a single bond, alkyl, allyl and propynyl; Y and Y1 denote H, OCF3, S(O)nCF3, S(O)nAlk, SO2CHF2, SO2CF2CF3, -O-CF2-CHF2, -O-CHF2, -O-CH2-CF3, SF5 and SO2NR5R6, whereby R5 and R6 are selected from among hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, aryl and heteroaryl, which are optionally substituted, or R5 and R6, together with N to which they are bound, form a heterocyclic radical; A2 denotes Al, CO and SO2; B2 denotes a heterocyclic radical which is optionally substituted with one or more substituents which are selected from the values of Y2; Y2 denotes hydrogen, halogen, hydroxyl, cyano, alkyl, alkoxy, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, -O-alkenyl, -O-alkynyl, O-cycloalkyl, S(O)n-alkyl, -S(O)n-alkenyl, -S(O)n-alkynyl, S(O)n-cycloalkyl, -COOR13,-OCOR13, NR5R6, CONR5R6, S(O)n-NR5R6,-NR10-CO-R13, -NR10-SO2-R13, -NH-SO2-NR5R6, -NR10-CO-NR5R6, -NR10-CS-NR5R6, -NR10-COOR13, all of said radicals being optionally substituted; and n denotes an integer of between 0 and 2. The aforementioned products are in all the isomeric forms and the salts thereof for use as medicaments. | ||||||
| 172 | THIAZOLO-PYRAMIDINE / PYRIDINE UREA DERIVATIVES AS ADENOSINE A2B RECEPTOR ANTAGONISTS | EP07728869.4 | 2007-05-08 | EP2027132B1 | 2010-09-15 | BRINKMAN, John A.; CHEUNG, Adrian Wai-Hing; FIROOZNIA, Fariborz; GUERTIN, Kevin Richard; MARCOPULOS, Nicholas; QI, Lida; RACHA, Jagdish Kumar; SARABU, Ramakanth; TAN, Jenny; TILLEY, Jefferson Wright |
| There are presented compounds of the formula (I) wherein R1, R2, R3 and R4 are as defined in the description and claims, or a pharmaceutically acceptable salt thereof, which are active adenosine A2B receptor antagonists and useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea. | ||||||
| 173 | NOVEL TYROSINE KINASES INHIBITORS | EP03774510 | 2003-10-01 | EP1545543A4 | 2010-03-10 | WITTMAN MARK D; BALASUBRAMANIAN NEELAKANTAN; VELAPARTHI UPENDER; ZIMMERMANN KURT; SAULNIER MARK G; LIU PEIYING; SANG XIAOPENG; FRENNESSON DAVID B; STOFFAN KAREN M; TARRANT JAMES G; MARINIER ANNE; ROY STEPHAN |
| 174 | INHIBITORS OF HISTONE DEACETYLASE | EP08748100.8 | 2008-04-09 | EP2139850A1 | 2010-01-06 | TESSIER, Pierre; LEIT, Silvana; SMIL, David; DÉZIEL, Robert; AJAMIAN, Alain; CHANTIGNY, Yves, Andre; DOMINGUEZ, Celia |
| This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula compounds of the Formula (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein groups L, M, X and Y are as defined herein. | ||||||
| 175 | METHOD FOR DETECTING PATHOGENIC MICROORGANISMS AND ANTIMICROBIAL AGENTS, METHOD FOR EVALUATING THE DRUG EFFECT OF ANTIMICROBIAL AGENTS, AND ANTIMICROBIAL AGENTS | EP00944390.4 | 2000-07-11 | EP1205559B1 | 2009-06-24 | TATSUMI, Yoshiyuki; YOKOO, Mamoru; NAKAMURA, Kosho; ARIKA, Tadashi |
| A novel method for evaluating the drug effect of an antimicrobial agent which comprises eliminating the antimicrobial agent remaining in a biological sample, etc. to thereby accurately evaluate the drug effect of the antimicrobial agent without being affected by the remaining antimicrobial agent. Remedies for nail mycosis which can be obtained by the drug effect evaluation method as described above. | ||||||
| 176 | Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen | EP09152706.9 | 2006-04-19 | EP2060575A1 | 2009-05-20 | Pouzet, Pascale; Hoenke, Christoph; Martyres, Domnic; Nickolaus, Peter; Jung, Birgit |
Die Erfindung betrifft neue Dihydrothienopyrimidine der Formel 1, sowie pharmakologisch verträgliche Salze, Diastereomere, Enantiomere, Racemate, Hydrate oder Solvate davon,
|
||||||
| 177 | BETA-SECRETASE INHIBITORS AND METHODS OF USE | EP02793826 | 2002-10-23 | EP1448218A4 | 2009-01-14 | GHOSH ARUN K; TANG JORDAN; BILCER GEOFFREY; CHANG WANPIN; HONG LIN; KOELSCH GERALD; LOY JEFF; TURNER ROBERT T III |
| 178 | SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS | EP07701434.8 | 2007-02-02 | EP1984333A1 | 2008-10-29 | CHAPLIN, Jason, Hugh; GILL, Gurmit, Singh; GROBELNY, Damian, Wojciech; FLYNN, Bernard, Luke; KREMMIDIOTIS, Gabriel |
| The present invention relates generally to substituted benzofurans, benzothiophenes, and indoles and their use as tubulin polymerisation inhibitors. | ||||||
| 179 | USE OF COMPOUNDS HAVING AN AMINE NUCLEUS IN MANUFACTURE OF A MEDICAMENT USEFUL FOR TREATING FACTOR VIIA-ASSOCIATED CONDITIONS | EP03742043 | 2003-06-17 | EP1532103A4 | 2008-03-05 | HERPIN TIMOTHY; BISACCHI GREGORY S; PI ZULAN; PRIESTLEY E SCOTT; DHAR T G MURALI |
| 180 | N-THIO-NICOTINAMID DERIVATE UND VERWANDTE VERBINDUNGEN ZUR VERWENDUNG ALS SCHÄDLINGSBEKÄMPFUNGSMITTEL | EP02762475.8 | 2002-09-13 | EP1432313B1 | 2008-01-23 | BECKMANN, Marion; ORT, Oswald; DÖLLER, Uwe; KRAUTSTRUNK, Gerhard; SCHAPER, Wolfgang; LÜMMEN, Peter; JANS, Daniela; HEMPEL, Waltraud; WAIBEL, Jutta, Maria; KÜHN, Barbara |
| The invention relates to compounds of formulas (I) and (II), wherein the symbols and indices have the meaning cited in the description. Said compounds are suitable for the control of animal pests. | ||||||
QQ群二维码
意见反馈
意见反馈